)
Visual24 Oct 2025
The rise of Alphabet
SCHOTT Pharma (1SXP) investor relations material
SCHOTT Pharma Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary12 Aug, 2025
Executive summary
Q3 revenue reached €256M, up 3% at constant currencies, driven by high-value solutions (HVS) and efficiency gains.
EBITDA for Q3 was €83M, with a record margin of 31.7%, reflecting favorable product mix and cost benefits.
HVS revenue share increased to 60%, up 5 points year-over-year, highlighting strategic focus and innovation.
Customer loyalty index reached 90 points, well above industry peers, reflecting strong trust and product quality.
New large volume and polymer cartridges were introduced, expanding the product portfolio for biologics and chronic disease treatments.
Financial highlights
Q3 revenues were €256M, up 3% year-over-year at constant currencies.
Q3 EBITDA increased 11% year-over-year to €83M, with a record margin of 31.7%.
Earnings per share for Q3 was €0.30, with a marginal 1% decrease due to higher depreciation and tax expenses.
Capital expenditure in Q3 was €38M, focused on growth investments.
Free cash flow for Q3 was €17M, down from €34M last year, mainly due to higher working capital and tax payments.
Outlook and guidance
Full-year organic revenue growth expected at 6% at constant currencies, revised to the lower end of previous guidance.
EBITDA margin for FY2025 expected to be around 28%, above previous guidance and last year's 26.9%.
HVS revenue share ambition raised to above 55%, with a mid-term target above 60%.
CapEx guidance reaffirmed at €140M–€160M for the full year.
Full-year tax rate anticipated at 22%, slightly above prior guidance due to regional earnings mix and global minimum taxation.
Why did DDS segment EBITDA decline?
Explain the increase in tax rate.
Detail drivers behind the 2025 revenue forecast change.
Quantify efficiency gains' margin contribution.
When will polymer syringe business grow?
Comment on U.S. revenue sequential change.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next SCHOTT Pharma earnings date
Q4 202511 Dec, 2025
Next SCHOTT Pharma earnings date
Q4 202511 Dec, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
SCHOTT Pharma AG & Co. KGaA specializes in developing, producing, and selling advanced drug containment and delivery solutions for the injectable drugs market. Catering to the pharmaceutical and biotechnology industries globally, the company offers a comprehensive portfolio that includes polymer and glass syringes, ampoules, vials, and cartridges. Notable products in its range include the syriQ series of glass and polymer syringes designed for various applications such as vaccines, biologics, aesthetic treatments, infusion therapy, and deep-cold applications, as well as the cartriQ and adaptiQ lines for cartridges and vials, respectively. It is headquartered in Mainz, Germany, and its shares are listed on the Frankfurt Stock Exchange.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage